未登录 返回 期刊详情
期刊论文 14 相关解读 0
Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX study 皮下注射达雷木单抗联合卡非佐米和地塞米松（D-Kd）与卡非佐米和地塞米松（Kd）在既往接受过达雷木单抗治疗的患者中的比较：LYNX研究 Bahlis, Nizar J.; Zonder, Jeffrey; Karlin, Lionel; Plesner, Torben; Paris, Laura; Wrobel, Tomasz; Hungria, Vania; Besemer, Britta; Crusoe, Edvan; Silkjaer, Trine; Perrot, Aurore; Moreau, Philippe; Wu, Ka Lung; Delimpasi, Sosana; Dimopoulos, Meletios A.; Levin, Mark-David; Mangiacavalli, Silvia; Nnane, Ivo; Kim, Yu Jin; Krevvata, Maria; Sha, Linlin; Wroblewski, Susan; Tuozzo, Alba; Carson, Robin; Facon, Thierry 分享 收藏
The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic review Park, H.; Robinson, J.; Flanagan, C.; Pawlyn, C.; Jackson, G.; Jones, J.R. 接受T细胞导向疗法治疗多发性骨髓瘤患者发生第二原发恶性肿瘤的风险：一项系统综述。Leuk. Lymphoma 2025, 1–10. [Google Scholar] [CrossRef] [PubMed] Park, Hyun; Robinson, Julian; Flanagan, Cliona; Pawlyn, Charlotte; Jackson, Graham; Jones, John R. 分享 收藏
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma 奥布替尼与维奈克拉联合治疗复发/难治性套细胞淋巴瘤患者 Lopedote, Paolo; Shouse, Geoffrey; Chen, Lu; Smith, Diane Lynne; Ford, Jessica; Herrera, Alex F.; Budde, Lihua E.; Siddiqi, Tanya; Kallam, Avyakta; Phillips, Tycel J.; Danilov, Alexey V. 分享 收藏
PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms PD-L1表达和对免疫检查点抑制剂治疗的反应在恶性组织细胞肿瘤中 Ravindran, Aishwarya; Jiang, Liuyan; Ruan, Gordon J.; Dasari, Surendra; Abeykoon, Jithma P.; Zanwar, Saurabh; Young, Jason R.; Bach, Corrie R.; Mcconathy, Jonathan E.; Bennani, N. Nora; Go, Ronald S.; Goyal, Gaurav; Rech, Karen L. 分享 收藏
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes 从维度到动力学再到结局——淋巴结和皮肤评估可预测CTCL结局 Kaminsky, Alexander; Fahmy, Lauren M.; Bilgrami, Zaid; Yang, Hye Ryung; Beylergil, Volkan; Zhou, Mengxi; Suhl, Sara; Bates, Susan E.; Fojo, Tito; Yang, Hao; Schwartz, Lawrence H.; Geskin, Larisa J. 分享 收藏
IGLV3-21 subset #2 without IGLV3-21R110 in chronic lymphocytic leukemia, is it possible? IGLV3-21亚组#2在慢性淋巴细胞白血病中不表达IGLV3-21R110，这是可能的吗？ Stanganelli, Carmen; Cardoso, Florencia; Cabrera, Juana; Damiani, German; de Dios Soler, Marcela; Garcia Montenegro, Mauro; Ledesma, Martin; Barreda, Mariangeles; Alderete, Natalia; Slavutsky, Irma 分享 收藏
Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison 慢性粒细胞白血病靶向治疗患者的认知: 对照比较 Hyland, Kelly A.; Eisel, Sarah L.; Hoogland, Aasha I.; Root, James C.; Bowles, Kris; James, Brian; Nelson, Ashley M.; Booth-Jones, Margaret; Jacobsen, Paul B.; Ahles, Tim A.; Jim, Heather S. L.; Gonzalez, Brian D. 分享 收藏
CHARACTERIZATION OF CD34(+) HUMAN HEMATOPOIETIC PROGENITOR CELLS FROM THE PERIPHERAL-BLOOD - ENZYME-CHEMISTRY, CARBOHYDRATE-CHEMISTRY AND IMMUNOCYTOCHEMISTRY, MORPHOMETRY, AND ULTRASTRUCTURE THIELE, J; WICKENHAUSER, C; BALDUS, SE; KUEMMEL, T; ZIRBES, TK; DREBBER, U; WIRTZ, R; THIEL, A; HANSMANN, ML; FISCHER, R 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
LEUKEMIA & LYMPHOMA.png)
.png)
分享.png)
收藏